Top Markets
Coin of the day
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Classement en actions #29359
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Prix de l'action
$0.365
Dernière synchronisation: 2025-08-01
Capitalisation boursière
$21.54M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Elevation Oncology, Inc. (ELEV)

Catégorie

Historique du prix de l'action pour Elevation Oncology, Inc. (ELEV)
Prix de clôture le plus élevé : $0.37 le 2025-08-01

Prix de clôture le plus bas : $12.36 le 2021-06-01
Historique du prix de l'action de Elevation Oncology, Inc. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2025 -40.93%
2024 21.56%
2023 -47.33%
2022 -81.61%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$546.78 39.93%
US
$1.02K 55.17%
NL
$153.64 450.47%
US
$117.42 -19.34%
AU
$753.28 8.59%
CH